Cytoplasmic TSC-22 (transforming growth factor-beta-stimulated clone-22) markedly enhances the radiation sensitivity of salivary gland cancer cells.
暂无分享,去创建一个
T. Fujimori | H. Yoshida | H. Kawamata | Y. Miwa | F. Omotehara | D. Uchida | N. Begum | Mitsunobu Sato | S. Hino
[1] T. Fujimori,et al. Nuclear translocation of TSC-22 (TGF-beta-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator. , 2000, Biochemical and biophysical research communications.
[2] M. Goumans,et al. Expression of TGF‐β stimulated clone‐22 (TSC‐22) in mouse development and TGF‐β signalling , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.
[3] H. Yoshida,et al. In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-beta stimulated clone-22. , 2000, Oncology reports.
[4] H. Yoshida,et al. Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. , 2000, Laboratory investigation; a journal of technical methods and pathology.
[5] L. Dobens,et al. Drosophila bunched integrates opposing DPP and EGF signals to set the operculum boundary. , 2000, Development.
[6] J. den Hertog,et al. Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. , 1999, The Journal of biological chemistry.
[7] L. Raftery,et al. Dynamic expression of TSC-22 at sites of epithelial-mesenchymal interactions during mouse development , 1999, Mechanisms of Development.
[8] H. Yoshida,et al. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. , 1998, Cancer research.
[9] B. van der Burg,et al. Novel Progesterone Target Genes Identified by an Improved Differential Display Technique Suggest That Progestin-induced Growth Inhibition of Breast Cancer Cells Coincides with Enhancement of Differentiation* , 1997, The Journal of Biological Chemistry.
[10] K. Yanagihara,et al. Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. , 1997, The Biochemical journal.
[11] A. N. Meyer,et al. Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Ohta,et al. Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. , 1996, European journal of biochemistry.
[13] S. Taviaux,et al. Cloning of the Human Homologue of the TGFβ-Stimulated Clone 22 Gene , 1996 .
[14] G. Rubin,et al. Shortsighted acts in the decapentaplegic pathway in Drosophila eye development and has homology to a mouse TGF-beta-responsive gene. , 1995, Development.
[15] A. Kania,et al. P-element mutations affecting embryonic peripheral nervous system development in Drosophila melanogaster. , 1995, Genetics.
[16] K. Hamil,et al. Cloning of rat Sertoli cell follicle-stimulating hormone primary response complementary deoxyribonucleic acid: regulation of TSC-22 gene expression. , 1994, Endocrinology.
[17] K. Nose,et al. Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. , 1992, The Journal of biological chemistry.
[18] T. Hunter,et al. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport , 1991, The Journal of cell biology.
[19] T. Bando,et al. An adenoid squamous carcinoma-forming cell line established from an oral keratinizing squamous cell carcinoma expressing carcinoembryonic antigen. , 1986, The American journal of pathology.
[20] H. Yoshida,et al. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. , 1998, British Journal of Cancer.